Tahithromos’s MasTec MTZ Stock Holding History

Tahithromos’s Portfolio MTZ Stock Details MTZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-548,659	Closed	-$18.1M	–	72
2013 Q2	$18.1M	Buy	+548,659	New	+$16.5M	3.46%	8

Other funds holding MTZ

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Peconic Partners New York $5.78B AUM 127.23% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Tahithromos's MTZ Position: Q3 2013 in Review

Tahithromos sold out of MasTec (MTZ) in Q3 2013, closing a stake of 548,659 shares — an estimated $18.1M sold.

Tahithromos first reported a position in MTZ in Q2 2013 and held it in 1 quarter. The position peaked at $18.1M in Q2 2013. 232 funds tracked by Wall St. Rank hold MTZ as of Q3 2013.

Tahithromos reported no remaining MasTec position as of Q3 2013 after selling out during the quarter.
Tahithromos sold 548,659 MasTec shares in Q3 2013, an estimated $18.1M.
Tahithromos first reported a position in MasTec in Q2 2013 and held it in 1 quarter.
Tahithromos's MasTec position peaked at $18.1M in Q2 2013.
232 funds tracked by Wall St. Rank held MasTec as of Q3 2013.

Based on Tahithromos's 13F filing for Q3 2013, filed 31 Oct 2013.